.tmb-1920v.png?sfvrsn=d6990130_1)
WHO COVID-19 Technology Access Pool
In May 2020, WHO and partners launched the COVID-19 Technology Access Pool (C-TAP) to facilitate timely, equitable and affordable access of COVID-19 health products by boosting their supply. C-TAP provides a global one-stop shop for developers of COVID-19 therapeutics, diagnostics, vaccines and other health products to share their intellectual property, knowledge, and data, with quality-assured manufacturers through public health-driven voluntary, non-exclusive and transparent licenses.
By sharing intellectual property and know-how through the pooling and these voluntary agreements, developers of COVID-19 health products can facilitate scale up production through multiple manufacturers that currently have untapped capacity to scale up production.
C-TAP was launched by WHO, in partnership with the Government of Costa Rica, under a global Solidarity Call to Action endorsed by nearly 40 Member States. WHO C-TAP implementing partners include the Medicines Patent Pool, Open COVID Pledge, UN Technology Bank and Unitaid. Developers of COVID-19 health technologies and holders of related knowledge, intellectual property and data are invited to "share their intellectual property, knowledge and data, and join the Solidarity Call to Action.”
Videos
Publications
Medical technologies – medicines, vaccines and medical devices – are essential for public health. Access to essential medicines and the lack...
19 October 2011
Global strategy and plan of action on public health, innovation and intellectual property
This publication is intended to be a reader-friendly and consolidated version of documents relevant to the global strategy and plan of action on public...
Other resources
- UN Technology Bank for the least developed countries
- WHO COVID-19 publications database
- WHO Emergency Use Listing Procedure
- WHO Global Observatory on Health R&D
- WHO ICTRP
- WTO COVID-19: Measures regarding trade-related intellectual property rights
- WIPO COVID-19 IP Policy Tracker
- COVID-19 Law Lab
- COVID-19 Research Project Tracker by UKCDR & GloPID-R
- Global Initiative on Sharing All Influenza Data (GISAID)
- Global Health Agreement Terms Glossary
- Knowledge Portal: COVID-19 Vaccine R&D Investments
- MedsPaL: The Medicines Patents and Licenses Database
- OECD Global Science Forum Research Funding Initiative
- Open COVID Pledge
- Policy Cures COVID-19 R&D Tracker
- RESIN: COVID-19 R&D funding interactive dashboard
- The FAIR Guiding Principles for scientific data management and stewardship
Documents
15 July 2021
Questionnaire on national, regional or global incentives to facilitate scale up and access to COVID-19 health technologies, including vaccines, diagnostics, and therapeutics
1 July 2021
Summary Report: Special press conference to mark the first anniversary of the COVID-19 Technology Access Pool
18 June 2021
C-TAP Civil Society Consultation Summary Note
16 January 2021
WHO COVID-19 Technology Access Pool (C-TAP) Civil Society Consultation
16 January 2021
C-TAP Enhancing global manufacturing capacity to address today's and tomorrow's pandemics
14 January 2021
WHO COVID-19 Technology Access Pool (C-TAP) Private Sector Consultation
27 October 2020
The Geneva Call: A joint appeal for Open Science
27 October 2020
C-TAP: A concept paper
13 October 2020
Extract: An integrated health, trade and IP approach to respond to the COVID-19 pandemic
28 September 2020
COVID-19 Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0
29 July 2020
WHO target product profiles for COVID-19 therapeutics
29 May 2020
Solidarity Call to Action
9 April 2020
WHO Target Product Profiles for COVID-19 Vaccines
18 May 2017